Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P H Vlasses

Showing results (21-30 of 169) with videos related to

Pageof 17
Sort By:
Archives of Internal Medicine|February 1, 1988
Role of the laboratory in treatment of the poisoned patientJ W Snyder, P H Vlasses
American Journal of Hospital Pharmacy|August 1, 1977
Third-party reimbursement for pharmacist instruction about antihemophilic factorR P Fudge, P H Vlasses
The American Journal of Medicine|September 4, 1998
Clinical trials in departments of internal medicineP H Vlasses, D A Burnett
Pharmacotherapy|February 24, 2001
A vision of pharmacy's future roles, responsibilities, and manpower needs in the United States. American Council on Pharmaceutical EducationP H Vlasses, J W Wadelin
Drug Intelligence & Clinical Pharmacy|November 1, 1982
Antihypertensive drug withdrawal syndromeD M Cummings, P H Vlasses
Drug Intelligence & Clinical Pharmacy|October 9, 1977
Mediset-induced over-complianceP H Vlasses, P Slutsky, E Taylor
Clinical Pharmacology and Therapeutics|October 1, 1988
Trimethoprim alters the disposition of procainamide and N-acetylprocainamideT Kosoglou, M L Rocci, P H Vlasses
Archives of Internal Medicine|November 1, 1991
Calcium antagonists in elderly and black hypertensive patients. Therapeutic controversiesW Zing, R K Ferguson, P H Vlasses
Pharmacotherapy|January 1, 1982
Captopril: clinical pharmacology and benefit-to-risk ratio in hypertension and congestive heart failureP H Vlasses, R K Ferguson, K Chatterjee
Drugs|June 1, 1987
Calcium antagonists in cerebral/peripheral vascular disorders. Current statusK J Tietze, M L Schwartz, P H Vlasses
Pageof 17

Showing results (21-30 of 169) with videos related to

Sort By:
Pageof 17
Archives of Internal Medicine|February 1, 1988
Role of the laboratory in treatment of the poisoned patientJ W Snyder, P H Vlasses
American Journal of Hospital Pharmacy|August 1, 1977
Third-party reimbursement for pharmacist instruction about antihemophilic factorR P Fudge, P H Vlasses
The American Journal of Medicine|September 4, 1998
Clinical trials in departments of internal medicineP H Vlasses, D A Burnett
Pharmacotherapy|February 24, 2001
A vision of pharmacy's future roles, responsibilities, and manpower needs in the United States. American Council on Pharmaceutical EducationP H Vlasses, J W Wadelin
Drug Intelligence & Clinical Pharmacy|November 1, 1982
Antihypertensive drug withdrawal syndromeD M Cummings, P H Vlasses
Drug Intelligence & Clinical Pharmacy|October 9, 1977
Mediset-induced over-complianceP H Vlasses, P Slutsky, E Taylor
Clinical Pharmacology and Therapeutics|October 1, 1988
Trimethoprim alters the disposition of procainamide and N-acetylprocainamideT Kosoglou, M L Rocci, P H Vlasses
Archives of Internal Medicine|November 1, 1991
Calcium antagonists in elderly and black hypertensive patients. Therapeutic controversiesW Zing, R K Ferguson, P H Vlasses
Pharmacotherapy|January 1, 1982
Captopril: clinical pharmacology and benefit-to-risk ratio in hypertension and congestive heart failureP H Vlasses, R K Ferguson, K Chatterjee
Drugs|June 1, 1987
Calcium antagonists in cerebral/peripheral vascular disorders. Current statusK J Tietze, M L Schwartz, P H Vlasses
Pageof 17